Evidence map›Paper›PMID 35921021›Full record

ArticleJournal of neuro-oncology2022

Outcomes following surgical resection of cystic intracranial meningiomas.

Alan R Tang, Silky Chotai, Candace J Grisham, Bradley S Guidry, Jake R McDermott, Chi H Le, Peter J Morone, Reid C Thompson, Lola B Chambless

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Alan R TangVanderbilt University Medical Center, 1161 21st Avenue South #D3300, Nashville, TN, 37232, USA.
Silky ChotaiDepartment of Neurological Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
Candace J GrishamVanderbilt University Medical Center, 1161 21st Avenue South #D3300, Nashville, TN, 37232, USA.
Bradley S GuidryVanderbilt University Medical Center, 1161 21st Avenue South #D3300, Nashville, TN, 37232, USA.
Jake R McDermottVanderbilt University, Nashville, TN, USA.
Chi H LeVanderbilt University Medical Center, 1161 21st Avenue South #D3300, Nashville, TN, 37232, USA.
Peter J MoroneDepartment of Neurological Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
Reid C ThompsonDepartment of Neurological Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
Lola B ChamblessDepartment of Neurological Surgery, Vanderbilt University Medical Center, Nashville, TN, USA. lola.chambless@vumc.org.
Vanderbilt University Medical Center · USNeurological Surgery · USVanderbilt University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCystic meningiomas are rare, accounting for 2-7% of all intracranial meningiomas. Little is known regarding whether these meningiomas behave differently compared to solid meningiomas. We sought to study this relatively uncommon imaging appearance of meningioma and to evaluate its clinical significance.

methodsA single-institution retrospective cohort study of surgically-treated meningioma patients between 2000 and 2019 was conducted. Cystic meningioma was defined as a tumor with an intratumoral or peritumoral cyst present on preoperative imaging. Demographics, preoperative imaging, histopathology characteristics, operative data, and surgical outcomes were reviewed. Imaging variables, histopathology and outcomes were reported for cystic meningiomas and compared with non-cystic meningiomas. Univariate/multivariable analyses were conducted.

resultsOf 737 total meningiomas treated surgically, 38 (5.2%) were cystic. Gross total resection (GTR) was achieved in 84.2% of cystic meningioma patients. Eighty-two percent of cystic meningiomas were WHO grade I (n = 31), 15.7% were grade II and 2.6% were grade III. Most cystic meningiomas had low Ki-67/MIB-1 proliferation index (n = 24, 63.2%). A total of 18.4% (n = 7) patients with cystic meningioma had recurrence compared to 12.2% (n = 80) of patients with non-cystic meningioma (p = 0.228). No significant difference in median time to recurrence was observed between cystic and non-cystic meningiomas (25.4, Q1:13.9, Q3:46.9 months vs. 13.4, Q1:8.6, Q3:35.5 months, p = 0.080).

conclusionsA small portion of intracranial meningiomas have cystic characteristics on imaging. Cystic meningiomas are frequently WHO grade I, have low proliferation index, and had similar outcomes compared to non-cystic meningioma. Cysts in meningioma may not be a surrogate to determine aggressive meningioma behavior.

Indexed as

CystsMeningeal NeoplasmsMeningiomaHumansNeoplasm Recurrence, LocalRetrospective StudiesClinical outcomesCystic meningiomaIntracranial tumorRecurrence

Identifiers

PMID35921021
OpenAlexW4289549848

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.